PPG - Bioprodutos e Bioprocessos
URI Permanente para esta coleção
Navegar
Navegando PPG - Bioprodutos e Bioprocessos por Palavras-chave "Actinomycetes"
Agora exibindo 1 - 1 de 1
Resultados por página
Opções de Ordenação
- ItemSomente MetadadadosBioprospecção de actinomicetos com potencial anticâncer em sedimentos marinhos de praias e ilhas da estância balneária de Ubatuba, SP(Universidade Federal de São Paulo (UNIFESP), 2020-02-04) Souza, Bruna Viana De [UNIFESP]; Jimenez, Paula Christine [UNIFESP]; Universidade Federal de São PauloWith the increasing need of new drugs for treatment of complex diseases, that still don’t have a selective and effective treatment, as cancer and neurodegenerative diseases, the bioprospection of natural drugs has grown a bit more each day. For the past few decades, the oceans have been showing their irrefutable pharmacological importance, mainly when related to new molecules isolated from actinomycetes. The objective of this study was to analyze the anticancer potential of crude extracts produced by actinomycetes, isolated from the marine sediment of Ubatuba, Brasil. Samples of sediment from 10 different beaches and islands, in the chosen area, were collected and pre-treated by two different methodologies, in order to favor the growth of the bacteria desired, then isolated using three distinct culture media, with variated nutritional supply. In total, 92 strains were isolated and cryopreserved, and 80 strains were grown in liquid media, extracted with solvent and tested for cytotoxicity in human colorectal cancer cells (HCT-116). Among the tested extracts, in qualitative MTT assay for HCT-116 cells, 20 demonstrated cell growth inhibition greater than 75% on the higher of the two concentrations used, 5µg/mL and 50µg/ mL, with 4 of them being active in both concentrations, and all were evaluated to obtain its IC50. Therefore, the strains BRB 539, BRB 592, BRB 607 e BRB 609, were proven to fit the prestablished standards for activity and pharmacologically interesting strains (IC50 < 4 µg/mL; R2 > 0,8500), and submitted to a quantitative cytotoxic essay using a cell line panel, formed by 3 cancerous cell lines (Sk-Mel-19, 501-Mel, MCF-7) and one non-tumor cell line (RPE-1). Moreover, the strains BRB 592 and BRB 607, were selected as more interesting for the study, analyzed in a cell growth vs cytotoxicity assay, and identified as Bacillus subtilis spizizenii and Micromonospora aurantiaca, respectively. Both identified species are known for their capability of producing active biocompounds, mainly with antibiotic and anticancer activity, proving the pharmacological relevance of the marine microorganisms inhabiting the sediments in the region of Ubatuba.